This department is offering a grant for developing sustained release strategies for HIV treatment or prevention. The grant aims to support projects that focus on delivering treatment or prevention products through sustained release platforms such as oral, injection, implant, or direct delivery to HIV target mucosa. The products should provide a minimum of 1 week for oral treatment or at least once a month for other drug delivery systems for prevention and treatment. Closing date for applications is January 7, 2022, at 12:00 AM EST.
Opportunity ID: 321482
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-20-029 |
Funding Opportunity Title: | Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01 Clinical Trial Not Allowed) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Oct 10, 2019 |
Last Updated Date: | Oct 10, 2019 |
Original Closing Date for Applications: | Jan 07, 2022 |
Current Closing Date for Applications: | Jan 07, 2022 |
Archive Date: | Feb 12, 2022 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | For profit organizations other than small businesses Public housing authorities/Indian housing authorities City or township governments Others (see text field entitled “Additional Information on Eligibility” for clarification) County governments Native American tribal governments (Federally recognized) Small businesses State governments Private institutions of higher education Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this Funding Opportunity Announcement (FOA) is to encourage grant applications that address the long term goal and objective of developing sustained release strategies for HIV treatment or prevention. Applications may propose treatment or prevention products delivered using sustained release platforms (oral, injection, implant or direct delivery to HIV target mucosa) that will provide a minimum of 1 week for oral (treatment) or a minimum of once a month for all other drug delivery systems for prevention and treatment. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-20-029.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-F | Use for due dates on or before January 24, 2022 | PKG00259206 | Dec 06, 2019 | Jan 24, 2022 | View | |
FORMS-E | Use for due dates on or before May 24, 2020 | PKG00255768 | Dec 06, 2019 | May 24, 2020 | View | |
FORMS-G | Use for due dates on or after January 25, 2022 | PKG00269726 | Oct 28, 2021 | Jan 07, 2022 | View |
Package 1
Mandatory forms
321482 RR_SF424_2_0-2.0.pdf
321482 PHS398_CoverPageSupplement_5_0-5.0.pdf
321482 RR_OtherProjectInfo_1_4-1.4.pdf
321482 PerformanceSite_2_0-2.0.pdf
321482 RR_KeyPersonExpanded_2_0-2.0.pdf
321482 PHS398_ResearchPlan_4_0-4.0.pdf
321482 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
321482 RR_Budget_1_4-1.4.pdf
321482 RR_SubawardBudget30_1_4-1.4.pdf
321482 PHS398_ModularBudget_1_2-1.2.pdf
321482 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
321482 RR_SF424_2_0-2.0.pdf
321482 PHS398_CoverPageSupplement_4_0-4.0.pdf
321482 RR_OtherProjectInfo_1_4-1.4.pdf
321482 PerformanceSite_2_0-2.0.pdf
321482 RR_KeyPersonExpanded_2_0-2.0.pdf
321482 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
321482 RR_Budget_1_4-1.4.pdf
321482 RR_SubawardBudget30_1_4-1.4.pdf
321482 PHS398_ModularBudget_1_2-1.2.pdf
321482 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 3
Mandatory forms
321482 RR_SF424_5_0-5.0.pdf
321482 PHS398_CoverPageSupplement_5_0-5.0.pdf
321482 RR_OtherProjectInfo_1_4-1.4.pdf
321482 PerformanceSite_4_0-4.0.pdf
321482 RR_KeyPersonExpanded_4_0-4.0.pdf
321482 PHS398_ResearchPlan_4_0-4.0.pdf
321482 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
321482 RR_Budget_3_0-3.0.pdf
321482 RR_SubawardBudget30_3_0-3.0.pdf
321482 PHS398_ModularBudget_1_2-1.2.pdf
321482 PHS_AssignmentRequestForm_3_0-3.0.pdf